MLTX — MoonLake Immunotherapeutics stock price, charts and financials

QT9MoonLake Immunotherapeutics

MoonLake Immunotherapeutics (NASDAQ: MLTX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
12.39
+0.04+0.32%
OverviewShort InterestFilings
MLTXQT9MoonLake Immunotherapeutics·NASDAQ
12.39+0.32%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 10, 202610-QQuarterly report
Aug 10, 20268-KCurrent report
Aug 10, 2026S-3ASRS-3ASR
Aug 10, 2026S-8Registration of employee benefit securities
Jul 29, 20264Statement of changes in beneficial ownership
Jul 23, 20264Statement of changes in beneficial ownership
Jul 21, 20264Statement of changes in beneficial ownership
Jul 20, 20264Statement of changes in beneficial ownership
Jul 15, 20268-KCurrent report
Jul 13, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 29, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jun 25, 20268-KCurrent report
Jun 24, 2026424B5Prospectus
Jun 23, 20264Statement of changes in beneficial ownership
Jun 22, 2026424B5Prospectus
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20268-KCurrent report
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
#1 / 25 of 271
Page
▼
/ 11